S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(2.10%) $83.06
Gas
(1.98%) $1.752
Gold
(1.32%) $2 241.80
Silver
(0.97%) $24.99
Platinum
(1.33%) $921.80
USD/EUR
(0.39%) $0.927
USD/NOK
(0.88%) $10.86
USD/GBP
(0.12%) $0.792
USD/RUB
(0.13%) $92.56

Realtime updates for Chugai Pharmaceutical [4519.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—General
Last Updated28 Mar 2024 @ 02:15

-2.72% ¥ 5 766.00

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally...

Stats
Today's Volume 2.40M
Average Volume 2.41M
Market Cap 9 486.89B
EPS ¥0 ( 2024-01-31 )
Next earnings date ( ¥46.87 ) 2024-04-23
Last Dividend ¥40.00 ( 2023-06-29 )
Next Dividend ¥0 ( N/A )
P/E 28.20
ATR14 ¥2.64 (0.05%)

Volume Correlation

Long: -0.56 (weak negative)
Short: -0.63 (weak negative)
Signal:(36.254) Neutral

Chugai Pharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chugai Pharmaceutical Correlation - Currency/Commodity

The country flag 0.42
( neutral )
The country flag -0.24
( neutral )
The country flag -0.13
( neutral )
The country flag 0.02
( neutral )
The country flag -0.46
( neutral )
The country flag 0.19
( neutral )

Chugai Pharmaceutical Financials

Annual 2023
Revenue: ¥1 111.37B
Gross Profit: ¥698.06B (62.81 %)
EPS: ¥197.83
Q4 2023
Revenue: ¥273.81B
Gross Profit: ¥212.29B (77.53 %)
EPS: ¥55.44
Q3 2023
Revenue: ¥257.90B
Gross Profit: ¥179.64B (69.66 %)
EPS: ¥47.15
Q2 2023
Revenue: ¥267.42B
Gross Profit: ¥175.76B (65.72 %)
EPS: ¥50.57

Financial Reports:

No articles found.

Chugai Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥40.00
(N/A)
¥0
(N/A)
¥40.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Chugai Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.55 - good (85.53%) | Divividend Growth Potential Score: 6.93 - Stable (38.68%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥0.500 2000-03-28
Last Dividend ¥40.00 2023-06-29
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 48 --
Total Paid Out ¥538.17 --
Avg. Dividend % Per Year 0.00% --
Score 3.8 --
Div. Sustainability Score 8.55
Div.Growth Potential Score 6.93
Div. Directional Score 7.74 --
Next Divdend (Est)
(2024-04-08)
¥0 Estimate 3.75 %
Dividend Stability
0.30 Poor
Dividend Score
3.80
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9708.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
8769.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
7999.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
7261.T Ex Dividend Knight 2023-09-28 Annually 0 0.00%
6540.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
5936.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
4634.T Ex Dividend Junior 2023-12-28 Semi-Annually 0 0.00%
3904.T Ex Dividend Junior 2023-12-28 Sporadic 0 0.00%
3153.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
2127.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2931.5004.146.21[0 - 0.5]
returnOnAssetsTTM0.1681.2004.395.26[0 - 0.3]
returnOnEquityTTM0.2131.5008.7410.00[0.1 - 1]
payoutRatioTTM0.404-1.0005.96-5.96[0 - 1]
currentRatioTTM4.740.80010.008.00[1 - 3]
quickRatioTTM3.680.80010.008.00[0.8 - 2.5]
cashRatioTTM1.5911.5002.273.40[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM17 5341.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM249.382.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM204.252.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6561.0002.412.41[0.2 - 0.8]
operatingProfitMarginTTM0.4101.0003.803.80[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.5750.8009.507.60[0.5 - 2]
Total Score8.55

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM29.351.0007.140[1 - 100]
returnOnEquityTTM0.2132.509.1910.00[0.1 - 1.5]
freeCashFlowPerShareTTM204.252.0010.0010.00[0 - 30]
dividendYielPercentageTTM1.3781.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM249.382.0010.0010.00[0 - 30]
payoutRatioTTM0.4041.5005.96-5.96[0 - 1]
pegRatioTTM0.5231.5009.850[0.5 - 2]
operatingCashFlowSalesRatioTTM0.3691.0003.270[0.1 - 0.5]
Total Score6.93

Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators